Meeshanthini Dogan
Chief Executive Officer at CARDIO DIAGNOSTICS HOLDINGS, INC.
Net worth: 1 M $ as of 2024-04-29
Profile
Meeshanthini V.
Dogan is the founder of Cardio Diagnostics, Inc. which was founded in 2017.
She holds the title of Chief Executive Officer & Director at the company.
Currently, she is also the Chief Executive Officer & Director at Cardio Diagnostics Holdings, Inc. since 2022.
Dr. Dogan has an education background from the University of Iowa, with degrees in undergraduate, graduate, and doctorate studies.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-31 | 1,586,464 ( 7.35% ) | 1 M $ | 2024-04-29 |
Meeshanthini Dogan active positions
| Companies | Position | Start |
|---|---|---|
| CARDIO DIAGNOSTICS HOLDINGS, INC. | Chief Executive Officer | 2022-10-24 |
Cardio Diagnostics, Inc.
 Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The private company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Founder | 2017-04-30 |
Training of Meeshanthini Dogan
| University of Iowa | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CARDIO DIAGNOSTICS HOLDINGS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The private company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Health Services |
- Stock Market
- Insiders
- Meeshanthini Dogan